159 filings
DEFA14A
XGN
Exagen Inc
26 Apr 24
Additional proxy soliciting materials
5:07pm
ARS
2023 FY
XGN
Exagen Inc
26 Apr 24
Annual report to shareholders
9:23am
8-K
XGN
Exagen Inc
26 Apr 24
Exagen Inc. Announces Changes to the Board of Directors
8:32am
DEF 14A
XGN
Exagen Inc
Definitive proxy
26 Apr 24
8:31am
10-K
2023 FY
XGN
Exagen Inc
Annual report
18 Mar 24
9:26am
8-K
nk9ihjdh
18 Mar 24
Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 Results
8:00am
8-K
uohlix
8 Jan 24
Exagen Inc. Announces Select Preliminary Full-Year 2023 Results and Reaffirms Guidance
8:00am
8-K
udn6qq2zrl
11 Dec 23
Departure of Directors or Certain Officers
4:05pm
EFFECT
qp80 evov5
30 Nov 23
Notice of effectiveness
12:15am
424B5
rldguj852u5w4ew
29 Nov 23
Prospectus supplement for primary offering
5:11pm
CORRESP
q4h 044vuu
28 Nov 23
Correspondence with SEC
12:00am
UPLOAD
x1ghj
22 Nov 23
Letter from SEC
12:00am
424B5
got0yw2
20 Nov 23
Prospectus supplement for primary offering
8:00am
8-K
canmp
17 Nov 23
Entry into a Material Definitive Agreement
4:30pm
8-K
akaln6q5 g4
13 Nov 23
Exagen Inc. Reports Strong Third Quarter 2023 Results
4:05pm
8-K
if5s7 n3wbvis
26 Oct 23
Entry into a Material Definitive Agreement
4:05pm